Hearing Loss Genetic tests in Dubai & UAE

Compare available Hearing Loss Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Hearing Loss Genetic test prices

Showing 1–5 of 5 matching tests.

Hearing Loss Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5561 MAP1A Gene Hearing Loss Genetic Test This test evaluates the MAP1A gene for pathogenic variants associated with autosomal dominant hereditary hearing loss (DFNA49).	Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MAP1A gene", "Single-nucleotide variants (SNVs)", "Small insertions/deletions", "Copy-number variants (CNVs)"] Parameters [] Preparation ["No fasting required", "Sign informed consent", "Provide a three-generation pedigree"] Indications ["Individuals with post-lingual progressive sensorineural hearing loss", "Positive family history of deafness", "Known DFNA49 phenotype", "Unexplained bilateral hearing loss suggestive of autosomal dominant inheritance"] Measurement technique Confirm with laboratory Codes LOINC: 100006-1 ICD-10: H90.3, H91.9 Clinical summary This test evaluates the MAP1A gene for pathogenic variants associated with autosomal dominant hereditary hearing loss (DFNA49).
TEST-5638 MYO15A Gene Deafness, Autosomal Recessive Type 3 Genetic Test This genetic test identifies pathogenic variants in the MYO15A gene associated with autosomal recessive deafness type 3 (DFNB3). It helps confirm the diagnosis and assess recurrenc...	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYO15A gene", "Molecular diagnosis of DFNB3"] Parameters [] Preparation [] Indications ["Confirmation of suspected DFNB3", "Carrier testing for family planning", "Guidance for cochlear implantation candidacy"] Measurement technique Confirm with laboratory Codes LOINC: 81304-5 ICD-10: H90.5 Clinical summary This genetic test identifies pathogenic variants in the MYO15A gene associated with autosomal recessive deafness type 3 (DFNB3). It helps confirm the diagnosis and assess recurrence risk.
TEST-5707 MYO6 Gene Deafness Autosomal Dominant Type 22 (DFNA22) Genetic Test This genetic test evaluates the MYO6 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss (DFNA22). It identifies mutations linked to inherite...	Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYO6 gene", "Genetic mutations causing DFNA22"] Parameters [] Preparation ["Genetic counselling session required prior to testing", "Detailed family pedigree chart needed"] Indications ["Suspected autosomal dominant non-syndromic hearing loss (DFNA22)", "Genetic counseling for families with hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 81496-1 ICD-10: H90.3 Clinical summary This genetic test evaluates the MYO6 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss (DFNA22). It identifies mutations linked to inherited deafness.
TEST-5530 P2RX2 Gene Progressive Hearing Loss Genetic Test This test evaluates the P2RX2 gene for pathogenic variants associated with autosomal dominant progressive sensorineural hearing loss.	Whole Blood or Capillary Blood (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the P2RX2 gene"] Parameters [] Preparation ["No fasting or special preparation is required"] Indications ["Individuals with a family history of early-onset hearing loss", "Diagnostic confirmation prior to cochlear implant candidacy evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 21663-4 ICD-10: H90.3 Clinical summary This test evaluates the P2RX2 gene for pathogenic variants associated with autosomal dominant progressive sensorineural hearing loss.
TEST-5641 TRIOBP Gene Deafness (Autosomal Recessive Type 28) Genetic Test This test evaluates the TRIOBP gene for pathogenic variants associated with autosomal recessive deafness type 28 (DFNB28). It identifies mutations causing hereditary hearing loss.	Whole blood (EDTA), DNA, or FTA card	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRIOBP gene", "Point mutations", "Small insertions/deletions", "Copy-number variations"] Parameters [] Preparation ["No fasting required", "No medication abstinence required"] Indications ["Diagnosis of autosomal recessive deafness type 28 (DFNB28)", "Carrier screening in families with a history of DFNB28", "Clarification of hearing loss etiology"] Measurement technique Confirm with laboratory Codes LOINC: 93480-3 ICD-10: H90.5, Z82.2 Clinical summary This test evaluates the TRIOBP gene for pathogenic variants associated with autosomal recessive deafness type 28 (DFNB28). It identifies mutations causing hereditary hearing loss.

Category overview

Hearing Loss Genetic: overview

When a family history of deafness points toward a specific hereditary trait, getting precise molecular confirmation is crucial for proactive medical management and family planning. As a highly focused diagnostic tool in our Molecular Genetics services, Hearing Loss Genetic testing specifically targets the exact DNA mutations—such as those in the GJB2 or SLC26A4 genes—responsible for your family's unique auditory challenges. By leveraging cutting-edge diagnostic technology, this precise genomic screening provides the definitive data needed to assess carrier status, evaluate risks for future children, and safely guide tailored pediatric audiology interventions like cochlear implants. Consistently trusted by ENTs across the best diagnostic labs in the UAE, DNA Labs ensures strict patient confidentiality, unparalleled diagnostic accuracy, and highly efficient reporting. Protect your family's sensory future—book your hearing loss genetic testing in UAE, arrange a seamless home sample collection, or connect with our specialized genetic counselors today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.